Becton, Dickinson and Company (BDX)
NYSE • Healthcare
Last close at October 2, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Becton, Dickinson and Company keeps $8 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 5
in 32 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Becton, Dickinson beat consensus on both revenue and adjusted EPS in its preliminary third fiscal quarter of 2026 results, reported Aug. 6, with revenue down about 10% to about $5.0 billion from about $5.5 billion a year ago, topping the about $4.9 billion estimate by about 2%, and adjusted EPS of $3.23 above the $3.14 estimate by about 3% even as it fell about 12% from $3.68 a year ago. Net income dropped about 34% to roughly $377 million from $574 million a year earlier, while gross margin was near 47% and operating margin about 13% on operating income of about $663 million. Revenue was concentrated in the United States at about $2.9 billion, with international sales at about $1.8 billion. The company generated operating cash flow of about $2.1 billion and repurchased about $2.25 billion of stock. Consensus for the next period calls for EPS of $4.11 on revenue of $5.13 billion.
About Becton, Dickinson and Company
Becton, Dickinson and Company trades on the NYSE as BDX and operates in healthcare as a maker of medical supplies, devices, and related laboratory and diagnostic products. Across its global business, the company generated $21.8 billion of revenue in FY2025.
Today's Snapshot
BDX closed 0.7% below yesterday's close, while its sector was flat. Becton Dickinson tested PureWick, a urine-management device, in intensive-care units.
Trading Volume
Above 10d avg 1.5M
1.8M
vs S&P 500 Today
Underperforming Market
-1.49%
Updated: October 2, 2026 at 20:24 UTC
BDX Headlines
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$164.80 - $181.10Sell
- RSI (14)42.16Neutral
- Stochastic %K (14, 3, 3)18.05Buy
- MACD Level (12, 26)-0.34Sell
Peers & Related Assets
Get premium market insights delivered directly to your inbox.